Medical Microbiology articles for U.S. Department of Health and Human Services (HHS), United States of America (USA)

Time frame: 1 June 2025 - 30 May 2026
Count: 27

Article ‘Count’ for Medical Microbiology.

Journal Count Share
3 0.59
Estimating the effect of hepatitis C infection on multidrug-resistant tuberculosis treatment outcomes under hypothetical interventions on regimen composition and adherence 0.04
Optimizing the sensitivity of detection of respiratory syncytial virus infections in longitudinal studies using the combination of weekly sample testing and biannual serology 0.42
Estimating the undetected burden and the likelihood of strain persistence of drug-resistant iNeisseria gonorrhoeae/i 0.13
4 1.66
<atl>iCandida glabrata/i Emerges as the Most Common Cause of Candidemia: Analysis of a Large Hospital-Based Database, United States, 2016–2024</atl> 0.67
Estimated hepatitis C prevalence and viral clearance using residual sera from a large commercial laboratory—November 2023–September 2024 0.67
Risk Factors Associated With Progression to Clinical Candida auris Infection Among Adults With Previous Colonization—Florida, 2019–2023 0.22
Multimorbidity Profiles and Severe In-Hospital Outcomes in Adults with Respiratory Syncytial Virus 0.11
1 0.23
Health Benefits, Costs, and Cost-Effectiveness of Jail-Based Hepatitis C Elimination Strategies 0.23
1 0.29
Effectiveness and Impact of Maternal RSV Immunization and Nirsevimab on Medically Attended RSV in US Children 0.29
7 2.49
Age-Specific Concentrations and Seroprevalence of Antibodies Against Salmonella Enteritidis (O:9) and Salmonella Typhimurium (O:4,5) Across 3 Sites in Kenya 0.08
Rotavirus-specific IgA and IgG Patterns During the First Two Years of Life in the PREVAIL Birth Cohort 0.61
Bacterial Meningitis Epidemiology in Burkina Faso and Niger - High-Risk Countries in the Meningitis Belt of Sub-Saharan Africa, 2015-2023 0.34
Characterization of mouse-adapted Marburg and Ravn viruses in inbred BALB/c and outbred CD-1 mice 0.75
Detection of Carbapenem-Resistant Bacteria in Skilled Nursing Facility Wastewater 0.50
Insights Into Global Antimicrobial Resistance Dynamics Through the Sequencing of Enteric Bacteria From US International Travelers 0.10
GES-66: Characterization of a New β-Lactamase Gene Variant Detected in Klebsiella pneumoniae 0.11
1 0.80
Antibiotic and Antiviral Prescribing for Long‐Term Care Residents With a scpCOVID/scp‐19 Diagnosis, March 2020–July 2023 0.80
4 1.10
Pangenome dynamics and population structure of the zoonotic pathogen Salmonella enterica serotype Hadar 0.35
Patterns of genomic deletions in monkeypox virus during the 2022 outbreak in the United States 0.69
Correlates of risk of respiratory syncytial virus disease: a prospective cohort study 0.03
Respiratory syncytial virus hospitalisation by chronological month of age and by birth month in infants 0.03
2 0.08
Genomic epidemiology of the 2025 mpox epidemic in Sierra Leone 0.06
Impact of the indigenous rotavirus vaccine Rotavac in the Universal Immunization Program in India during 2016–2020 0.02
1 0.06
Pre-European contact leprosy in the Americas and its current persistence 0.06
2 0.25
Impact of introducing RTS,S/AS01E malaria vaccine on mortality in young children in Ghana, Kenya, and Malawi: an observational evaluation of a cluster-randomised implementation programme 0.10
Safety and efficacy of the monoclonal antibody L9LS for malaria prevention in children exposed to perennial malaria transmission in Kenya: a randomised, double-blind, placebo-controlled, phase 2 trial 0.14
1 0.10
Sustained efficacy of the RTS,S/AS01E malaria vaccine over 50 months of follow-up when used in full-dose or fractional-dose regimens in young children in Ghana and Kenya: final results from an open-label, phase 2b, randomised controlled trial 0.10

Numerical information only (in the tables above) is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International.